Zobrazeno 1 - 10
of 17
pro vyhledávání: '"M K Gorny"'
Autor:
D W Lineberger, M Ossorio-Castro, S Koenig, M K Gorny, Joseph Kessler, Susan Zolla-Pazner, Lynn J. Boots, Anthony J. Conley, Emilio A. Emini, Constance Williams
Publikováno v:
Journal of Virology. 68:6994-7000
Human monoclonal antibody 447-52D binds to the V3 determinant of the human immunodeficiency virus type 1 (HIV-1) gp120 external glycoprotein. Its binding requires the expression of the GPxR sequence at the center of the V3 domain. HIV-1 variants that
Publikováno v:
Journal of Virology. 65:4169-4176
Four of eight human monoclonal antibodies (huMAbs) to gp41 were identified which could enhance human immunodeficiency virus type 1 (HIV-1) infection in vitro by complement-mediated antibody-dependent enhancement (C'-ADE). These enhancing huMAbs were
Autor:
William M. Mitchell, T Sugano, E M Hersh, D Lake, M. K. Gorny, W E Robinson, Y Masuho, Jian-Yin Xu, Y. Matsumoto, Tetsuya Kawamura
Publikováno v:
Proceedings of the National Academy of Sciences. 87:3185-3189
Three of 16 human monoclonal antibodies (hu-mAbs) enhanced human immunodeficiency virus type 1 (HIV-1) infection of MT-2 target cells by means of a mechanism that is dependent on complement. Enhanced infections are characterized by an increase in cyt
Autor:
M K, Gorny, T C, VanCott, C, Hioe, Z R, Israel, N L, Michael, A J, Conley, C, Williams, J A, Kessler, P, Chigurupati, S, Burda, S, Zolla-Pazner
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 159(10)
Five human anti-V3 mAbs were generated from Ab-producing cells derived from the blood of HIV-1-infected individuals from North America and selected using the V3 peptide of a divergent clade B isolate, HIV(RF). The anti-V3(RF) mAbs were mapped to a cl
Publikováno v:
AIDS (London, England). 11(1)
Autor:
M K, Gorny, T, Keler, S, Burda, C, Williams, J L, Gabriel, W M, Mitchell, Y M, Deo, S, Zolla-Pazner
Publikováno v:
Antibiotics and chemotherapy. 48
Publikováno v:
Journal of virology. 68(6)
The ability of antibodies to the V3 region and the CD4-binding domain (CD4bd) of human immunodeficiency virus type 1 (HIV-1) to act in synergy to neutralize HIV has been demonstrated previously. However, synergy between antibodies to other HIV-1 epit
Autor:
J P, Moore, Y, Cao, A J, Conley, R, Wyatt, J, Robinson, M K, Gorny, S, Zolla-Pazner, D D, Ho, R A, Koup
Publikováno v:
Journal of acquired immune deficiency syndromes. 7(4)
Using human monoclonal antibodies (HuMAbs) r(1)-447 (L-736,523) and 19b to the V3 region of HIV-1 gp120, we have explored epitope presentation on V3-peptides and on the corresponding gp120 proteins. HuMAb r(1)-447 binds strongly to the MN and SF-2 pe
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 150(2)
HIV infection induces antibodies that mediate neutralization of cell-free virus and may protect against viral infection. Neutralizing human mAb that bind to the third hypervariable domain (V3) of gp120 have been generated from PBL of HIV-seropositive
Autor:
D S, Tyler, S D, Stanley, S, Zolla-Pazner, M K, Gorny, P P, Shadduck, A J, Langlois, T J, Matthews, D P, Bolognesi, T J, Palker, K J, Weinhold
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 145(10)
In an effort to determine the functional activity of anti-HIV-1 human mAb and to define the epitopes against which they are directed, supernatants from 10 EBV-transformed lymphoblastoid cell lines producing mAb to HIV were tested. Five clones produci